⌘K

Home/Filings/4/0001493152-23-011888

4//SEC Filing

Breen Michael Martin 4

Accession 0001493152-23-011888

CIK 0000109657other

View on SEC.gov Company Profile

Filed

Apr 10, 8:00 PM ET

Accepted

Apr 11, 6:59 PM ET

Size

4.8 KB

Accession

0001493152-23-011888

Insider Transaction Report

Form 4

Period: 2023-04-11

GT Biopharma, Inc.GTBP

Breen Michael Martin

Director

Transactions

Purchase
Common Stock
2023-04-11$0.50/sh+50,000$25,000→ 656,218 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

GT Biopharma, Inc.

CIK 0000109657

Entity typeother

Related Parties

1

filerCIK 0001863633

Filing Metadata

Form type: 4
Filed: Apr 10, 8:00 PM ET
Accepted: Apr 11, 6:59 PM ET
Size: 4.8 KB

View on SEC.gov